Zymeworks Inc
NASDAQ:ZYME

Watchlist Manager
Zymeworks Inc Logo
Zymeworks Inc
NASDAQ:ZYME
Watchlist
Price: 11.54 USD 0.52% Market Closed
Market Cap: 803m USD

Wall Street
Price Targets

ZYME Price Targets Summary
Zymeworks Inc

Wall Street analysts forecast ZYME stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ZYME is 22.84 USD with a low forecast of 13.13 USD and a high forecast of 31.5 USD.

Lowest
Price Target
13.13 USD
14% Upside
Average
Price Target
22.84 USD
98% Upside
Highest
Price Target
31.5 USD
173% Upside
Zymeworks Inc Competitors:
Price Targets
REGN
Regeneron Pharmaceuticals Inc
40% Upside
DVAX
Dynavax Technologies Corp
150% Upside
VCYT
Veracyte Inc
64% Upside
CRNX
Crinetics Pharmaceuticals Inc
160% Upside
688293
Shanghai OPM Biosciences Co Ltd
33% Upside
ADAG
Adagene Inc
466% Upside
STOK
Stoke Therapeutics Inc
160% Upside
2256
Abbisko Cayman Ltd
37% Upside

Revenue
Forecast

Revenue Estimate
Zymeworks Inc

For the last 8 years the compound annual growth rate for Zymeworks Inc's revenue is 27%. The projected CAGR for the next 3 years is 18%.

27%
Past Growth
18%
Estimated Growth
Estimates Accuracy
5%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Zymeworks Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-10%
Average Miss

Net Income
Forecast

Net Income Estimate
Zymeworks Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-32%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ZYME's stock price target?
Price Target
22.84 USD

According to Wall Street analysts, the average 1-year price target for ZYME is 22.84 USD with a low forecast of 13.13 USD and a high forecast of 31.5 USD.

What is Zymeworks Inc's Revenue forecast?
Projected CAGR
18%

For the last 8 years the compound annual growth rate for Zymeworks Inc's revenue is 27%. The projected CAGR for the next 3 years is 18%.

Back to Top